There has been increasing attention in the United States to problems of abuse of gamma-hydroxybutyrate
(GHB), with some evidence for problems in other parts of the world as well. In …

Recent human clinical studies with the NMDA receptor (NMDAR) antagonist ketamine have
revealed profound and long-lasting antidepressant effects with rapid onset in several clinical …

We have compared the potencies of structurally distinct channel blockers at recombinant
NR1/NR2A, NR1/NR2B, NR1/NR2C and NR1/NR2D receptors. The IC 50 values varied with …

Substance abuse and addiction are well recognized public health concerns, with 2 NIH
institutes (the National Institute on Drug Abuse and the National Institute on Alcohol Abuse and …

… Kate Nicholson was involved with analysis and interpretation of primary and subset data;
drafting of the manuscript; critical revision of the manuscript for important intellectual content …

Objective To determine the safety and efficacy of mesenchymal stem cell (MSC)-neurotrophic
factor (NTF) cells (NurOwn®, autologous bone marrow-derived MSCs, induced to secrete …

Stroke remains a significant problem despite decades of work on neuroprotective strategies.
NMDA receptor (NMDAR) antagonists are neuroprotective in preclinical models, but have …

Opioid tapering guidelines were created, in part, to decrease harm to patients resulting from
high-dose opioid therapy for chronic pain. However, countless “legacy patients” with chronic …

LBA154^ Background: The global SPACE trial was conducted to evaluate the efficacy and
safety of S in combination with TACE with DEBDOX in patients (pts) with intermediate-stage …

Current therapeutic development in amyotrophic lateral sclerosis (ALS) relies on individual
randomized clinical trials to test a specific investigational product in a single patient …